Klein, T. W. et al. The cannabinoid system and immune modulation. J. Leukoc. Biol.74, 486–496 (2003) ArticleCAS Google Scholar
Buckley, N. E. et al. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur. J. Pharmacol.396, 141–149 (2000) ArticleCAS Google Scholar
Rinaldi-Carmona, M. et al. SR144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther.284, 644–650 (1998) CASPubMed Google Scholar
Libby, P., Ridker, P. M. & Maseri, A. Inflammation and atherosclerosis. Circulation105, 1135–1143 (2002) ArticleCAS Google Scholar
Mach, F. Statins as immunomodulatory agents. Circulation109 (suppl.), II15–II17 (2004) PubMed Google Scholar
Srivastava, M. D., Srivastava, B. I. & Brouhard, B. Δ9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. Immunopharmacology40, 179–185 (1998) ArticleCAS Google Scholar
Zhu, L. X. et al. Δ-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J. Immunol.165, 373–380 (2000) ArticleCAS Google Scholar
Yuan, M. et al. Δ9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J. Neuroimmunol.133, 124–131 (2002) ArticleCAS Google Scholar
Lyman, W. D., Sonett, J. R., Brosnan, C. F., Elkin, R. & Bornstein, M. B. Δ9-Tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis. J. Neuroimmunol.23, 73–81 (1989) ArticleCAS Google Scholar
Malfait, A. M. et al. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc. Natl Acad. Sci. USA97, 9561–9566 (2000) ArticleADSCAS Google Scholar
Sulcova, E., Mechoulam, R. & Fride, E. Biphasic effects of anandamide. Pharmacol. Biochem. Behav.59, 347–352 (1998) ArticleCAS Google Scholar
Brenneisen, R., Egli, A., Elsohly, M. A., Henn, V. & Spiess, Y. The effect of orally and rectally administered Δ9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients. Int. J. Clin. Pharmacol. Ther.34, 446–452 (1996) CASPubMed Google Scholar
Chesher, G. B., Bird, K. D., Jackson, D. M., Perrignon, A. & Starmer, G. A. The effects of orally administered Δ9-tetrahydrocannabinol in man on mood and performance measures: a dose-response study. Pharmacol. Biochem. Behav.35, 861–864 (1990) ArticleCAS Google Scholar
Lichtman, A. H., Poklis, J. L., Poklis, A., Wilson, D. M. & Martin, B. R. The pharmacological activity of inhalation exposure to marijuana smoke in mice. Drug Alcohol Depend.63, 107–116 (2001) ArticleCAS Google Scholar
Varvel, S. A., Hamm, R. J., Martin, B. R. & Lichtman, A. H. Differential effects of Δ9-THC on spatial reference and working memory in mice. Psychopharmacology (Berl.)157, 142–150 (2001) ArticleCAS Google Scholar
Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L. & Ross, R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb.14, 133–140 (1994) ArticleCAS Google Scholar
Reddick, R. L., Zhang, S. H. & Maeda, N. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler. Thromb.14, 141–147 (1994) ArticleCAS Google Scholar
Tangirala, R. K., Rubin, E. M. & Palinski, W. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J. Lipid Res.36, 2320–2328 (1995) CASPubMed Google Scholar
Johnson, Z. et al. Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J. Immunol.173, 5776–5785 (2004) ArticleCAS Google Scholar
Daugherty, A. & Rateri, D. L. T lymphocytes in atherosclerosis: the yin-yang of Th1 and Th2 influence on lesion formation. Circ. Res.90, 1039–1040 (2002) ArticleCAS Google Scholar
Moeller, F. & Nielsen, L. B. Aortic recruitment of blood lymphocytes is most pronounced in early stages of lesion formation in apolipoprotein-E-deficient mice. Atherosclerosis168, 49–56 (2003) ArticleCAS Google Scholar
Song, L., Leung, C. & Schindler, C. Lymphocytes are important in early atherosclerosis. J. Clin. Invest.108, 251–259 (2001) ArticleCAS Google Scholar
Benagiano, M. et al. T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc. Natl Acad. Sci. USA100, 6658–6663 (2003) ArticleADSCAS Google Scholar
Laurat, E. et al. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation104, 197–202 (2001) ArticleCAS Google Scholar
Mulhaupt, F. et al. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells. Cardiovasc. Res.59, 755–766 (2003) ArticleCAS Google Scholar
Kwak, B. R. et al. Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice. Circulation107, 1033–1039 (2003) ArticleCAS Google Scholar
Giroud, C. et al. Δ9-THC, 11-OH-Δ9-THC and Δ9-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people. Forensic Sci. Int.123, 159–164 (2001) ArticleCAS Google Scholar
Hickey, M. J., Bullard, D. C., Issekutz, A. & James, W. G. Leukocyte-endothelial cell interactions are enhanced in dermal postcapillary venules of MRL/fas(lpr) (lupus-prone) mice: roles of P- and E-selectin. J. Immunol.168, 4728–4736 (2002) ArticleCAS Google Scholar
Veillard, N. R., Steffens, S., Burger, F., Pelli, G. & Mach, F. Differential expression patterns of proinflammatory and antiinflammatory mediators during atherogenesis in mice. Arterioscler. Thromb. Vasc. Biol.24, 2339–2344 (2004) ArticleCAS Google Scholar